Correlation Between Bristol Myers and NEC

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bristol Myers and NEC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol Myers and NEC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bristol Myers Squibb and NEC Corporation, you can compare the effects of market volatilities on Bristol Myers and NEC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol Myers with a short position of NEC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol Myers and NEC.

Diversification Opportunities for Bristol Myers and NEC

-0.44
  Correlation Coefficient

Very good diversification

The 3 months correlation between Bristol and NEC is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and NEC Corp. in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NEC Corporation and Bristol Myers is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with NEC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NEC Corporation has no effect on the direction of Bristol Myers i.e., Bristol Myers and NEC go up and down completely randomly.

Pair Corralation between Bristol Myers and NEC

Assuming the 90 days horizon Bristol Myers Squibb is expected to generate 0.56 times more return on investment than NEC. However, Bristol Myers Squibb is 1.79 times less risky than NEC. It trades about 0.12 of its potential returns per unit of risk. NEC Corporation is currently generating about 0.03 per unit of risk. If you would invest  73,550  in Bristol Myers Squibb on September 16, 2024 and sell it today you would earn a total of  18,672  from holding Bristol Myers Squibb or generate 25.39% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy96.88%
ValuesDaily Returns

Bristol Myers Squibb  vs.  NEC Corp.

 Performance 
       Timeline  
Bristol Myers Squibb 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Bristol Myers Squibb are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Even with relatively fragile primary indicators, Bristol Myers reported solid returns over the last few months and may actually be approaching a breakup point.
NEC Corporation 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in NEC Corporation are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak basic indicators, NEC may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Bristol Myers and NEC Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bristol Myers and NEC

The main advantage of trading using opposite Bristol Myers and NEC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol Myers position performs unexpectedly, NEC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NEC will offset losses from the drop in NEC's long position.
The idea behind Bristol Myers Squibb and NEC Corporation pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Complementary Tools

Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments